In imiquimod-induced mouse models, TNFR1 knockout significantly reduces skin inflammation (96), whereas TNFR2 deletion increases neutrophil infiltration and IL-23 expression, worsening disease progression (97). The gene discussed is IL23A; the disease is dermatitis.